The U.S. Preventive Services Task Force is a panel of 16 outside experts who grade screenings and preventive care. If it gives a service an A or B, most private insurers have to cover it at no cost to patients. The panel hasn't met to work on recommendations since March 2025, and the health department kept canceling or postponing its meetings. In May, Health and Human Services Secretary Robert F. Kennedy Jr. removed its two vice chairs. In September he added eight new members, and five of them are specialists. The panel met that month only for orientation. Now it meets Thursday and Friday to take up stalled guidance on cervical cancer screening, perinatal depression and unhealthy alcohol use. Current recommendations stay in effect for now.

1. Specialists Will Make the Panel Sharper

Kennedy says the old panel was slow, and the new specialists bring real expertise.

The old panel let people down. Kennedy told a House committee in April that the task force "has been lackadaisical and negligent for 20 years." Republican senators had earlier accused it of putting "wokeness" ahead of science. Kennedy says the new members will make sure it "asks hard questions."

Doctors who treat a disease can read its evidence better. "We need specialists at the table," Kennedy wrote in a Fox News op-ed. He said a cardiologist can catch things in heart screening research that others miss. He kept eight members from the Biden years, and he says primary care voices "remain essential." His department's research agency calls the roster "some of the most accomplished national experts ever to serve."

The stock waivers are legal and limited. HHS spokeswoman Emily Hilliard said a lawful waiver is "an appropriate remedy for a conflict of interest." Dr. Roger Klein, an official at the agency that runs the panel, noted that one member out of 16 can't make a final government decision.

2. But Primary Care Doctors Should Run It

Primary care advocates say the panel works because it's built around the clinicians who deliver everyday prevention.

Specialists see patients after a test comes back positive. Aaron Carroll, who runs the health research group AcademyHealth, said the panel is "built around people who deliver preventative care, not people who deliver care after a positive test." Carroll said specialists usually come in to explain their tests but rarely sit on the panel, partly to avoid conflicts of interest.

The new lineup breaks from how the panel has always worked. The American Medical Association said the new members "represent a significant departure from the Task Force's traditional membership." AMA President Dr. Willie Underwood III said a "strong primary care voice must remain central."

3. And Members Shouldn't Own Drug Stocks

Ethics critics say members who could profit from the panel's decisions shouldn't be making them.

Four new members kept their health company stocks. The New York Times reported that four of the eight new appointees got waivers to keep holdings in companies like Eli Lilly, Merck and Pfizer. STAT reported that two members own private practices that could profit if the panel recommends certain care. Before this administration, candidates with holdings like these were generally expected to sell them or skip the job.

Congress should write the rules into law. Senator Angus King of Maine and Senator Elizabeth Warren of Massachusetts introduced a bill last week to set conflict-of-interest rules and restore primary care standards for members. King said the panel has worked for more than 40 years "because it has let science and data lead." The bill comes as Democrats prepare to take control of Congress in January.

Where This Lands

Kennedy says specialists will make a slow panel sharper and more rigorous. Primary care advocates say primary care doctors should lead the panel, and specialists belong in the room as advisers. Ethics critics and two senators say members with drug stocks and private practices shouldn't grade the care they profit from. This week the panel takes up the stalled cervical cancer, depression and alcohol guidance, its first real work since the shakeup.

Sources